These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 495276)

  • 1. Heterogeneity of insulin responses in maturity-onset type diabetes (MOD) and in maturity-onset type diabetes of young people (MODY).
    Fajans SS
    Adv Exp Med Biol; 1979; 119():171-5. PubMed ID: 495276
    [No Abstract]   [Full Text] [Related]  

  • 2. C-Peptide responses to glucose load in maturity-onset diabetes of the young (MODY).
    Mohan V; Snehalatha C; Ramachandran A; Jayashree R; Viswanathan M
    Diabetes Care; 1985; 8(1):69-72. PubMed ID: 3882370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity within type II and MODY diabetes.
    Fajans SS
    Adv Exp Med Biol; 1985; 189():65-87. PubMed ID: 3898767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes.
    Doria A; Yang Y; Malecki M; Scotti S; Dreyfus J; O'Keeffe C; Orban T; Warram JH; Krolewski AS
    Diabetes Care; 1999 Feb; 22(2):253-61. PubMed ID: 10333942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of insulin responses in latent diabetes.
    Fajans SS; Floyd JC; Taylor CI; Pek S
    Trans Assoc Am Physicians; 1974; 87():83-94. PubMed ID: 4456739
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase of insulin concentration in maturity-onset diabetics by phentolamine (Regitine) infusion.
    Linde J; Deckert T
    Horm Metab Res; 1973 Nov; 5(6):391-5. PubMed ID: 4766993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of obesity and maturity-onset diabetes on the kinetics of NEFA during oral glucose tolerance tests (OGTT)].
    Pasquali R; Parenti M; Della Rocca E; Rago S; Bianchi V; Gallo C; Calliva R; Melchionda N
    G Clin Med; 1979 Jul; 60(7):549-59. PubMed ID: 398303
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA antigens in a family with maturity-onset type diabetes mellitus.
    Faber OK; Thomsen M; Binder C; Platz P; Svejgaard A
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):329-38. PubMed ID: 580833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus.
    Doar JW; Wilde CE; Thompson ME; Sewell PF
    Lancet; 1975 Jun; 1(7919):1263-6. PubMed ID: 48896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clofibrate on glucose tolerance in maturity onset diabetes.
    Barnett D; Craig JG; Robinson DS; Rogers MP
    Br J Clin Pharmacol; 1977 Aug; 4(4):455-8. PubMed ID: 901737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma trivalent chromium, glucose tolerance and insulin secretion in juvenile- and adult-onset diabetes mellitus.
    Gedik O; Unal S; Koray Z
    Isr J Med Sci; 1980 Aug; 16(8):563-5. PubMed ID: 6998922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The various faces of diabetes in the young: changing concepts.
    Fajans SS; Floyd JC; Tattersall RB; Williamson JR; Pek S; Taylor CI
    Arch Intern Med; 1976 Feb; 136(2):194-202. PubMed ID: 1247351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus.
    Ferrari C; Romussi M; Bertazzoni A; Testori GP; Grimaldi MG
    Biomedicine; 1978 Jun; 29(4):133-6. PubMed ID: 556385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucose, insulin, glucagon, and growth hormone in kindreds with maturity-onset type of hyperglycemia in young people.
    Barbosa J; Ramsay R; Goetz FC
    Ann Intern Med; 1978 May; 88(5):595-601. PubMed ID: 646240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bromocriptine on maturity onset diabetes.
    Barnett AH; Chapman C; Gailer K; Hayter CJ
    Postgrad Med J; 1980 Jan; 56(651):11-4. PubMed ID: 6992131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young.
    Velho G; Froguel P; Clement K; Pueyo ME; Rakotoambinina B; Zouali H; Passa P; Cohen D; Robert JJ
    Lancet; 1992 Aug; 340(8817):444-8. PubMed ID: 1354782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of physical training on glucose tolerance and plasma lipids in maturity-onset diabetes.
    Ruderman NB; Ganda OP; Johansen K
    Diabetes; 1979 Jan; 28 Suppl 1():89-92. PubMed ID: 761721
    [No Abstract]   [Full Text] [Related]  

  • 18. [Insulin response to the oral glucose tolerance test in obese patients and in subjects with a family history of diabetes mellitus].
    Fernandez Feo N; Betancourt de Breña A
    Acta Cient Venez; 1988; 39(5-6):443-6. PubMed ID: 3077893
    [No Abstract]   [Full Text] [Related]  

  • 19. Immuno reactive insulin responses to glycemic stimulus in maturity onset diabetics effect of severity and body weight.
    Viswanathan M; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1978 Aug; 26(8):687-93. PubMed ID: 754707
    [No Abstract]   [Full Text] [Related]  

  • 20. [Frequency of diabetes mellitus and beta pancreatic secretion in offspring of patients with MODY (maturity onset diabetes in the young)].
    Durruty P; Muñoz S; García de los Ríos M
    Rev Med Chil; 1987 May; 115(5):404-10. PubMed ID: 3329378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.